Loading clinical trials...
Loading clinical trials...
Acanthosis nigricans (AN) is increasing in its prevalence and is the most prevalent cutaneous manifestation in individuals with obesity. Insulin resistance or hyperinsulinemia is the main pathophysiol...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Shen Qu
NCT07446972 · Morbid Obesity
NCT02024542 · Morbid Obesity
NCT07565051 · Morbid Obesity Requiring Bariatric Surgery
NCT02861781 · Obesity, Insulin Resistance, and more
NCT07415720 · Diabete Type 2, Obesity & Overweight, and more
Shanghai Tenth People's Hospital
Shanghai
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions